MISHA Post-Market Clinical Study
NCT: NCT06118892 · RECRUITING
Brief Summary
Prospective evaluation of the safety and effectiveness of the MISHA Knee System. The study will collect data on the procedural and long-term adverse events, WOMAC pain and function scores, KSS satisfaction, subsequent surgical interventions, BMI levels, range of motion, UCLA activity level of the subjects, and perform radiographic/x-ray evaluations at clinical visits through 5 years post-procedure. The primary analysis of this study is freedom from device- and procedure-related SSIs at five (5) years post-implantation. This study will also assess device performance in subjects with intact and retained devices and subjects with devices removed prior to study termination and freedom from conversion to arthroplasty through 5 years. Study subjects will be followed over a five-year post-implant period.
Frequently Asked Questions
What is MISHA Post-Market Clinical Study?
MISHA Post-Market Clinical Study is a clinical trial registered under NCT06118892. Current status: RECRUITING.
What is the status of NCT06118892?
The current status of NCT06118892 (MISHA Post-Market Clinical Study) is: RECRUITING.
When did MISHA Post-Market Clinical Study start?
MISHA Post-Market Clinical Study started on 2023-11-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.